0000849146-24-000010.txt : 20240103 0000849146-24-000010.hdr.sgml : 20240103 20240103162433 ACCESSION NUMBER: 0000849146-24-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fife Steven R CENTRAL INDEX KEY: 0001408954 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35647 FILM NUMBER: 24506882 MAIL ADDRESS: STREET 1: C/O LECG 2000 POWELL STREET, STE 600 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 900224471 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 BUSINESS PHONE: 801-432-9000 MAIL ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 4 1 wk-form4_1704317051.xml FORM 4 X0508 4 2024-01-01 0 0000849146 Lifevantage Corp LFVN 0001408954 Fife Steven R 3300 NORTH TRIUMPH BLVD #700 LEHI UT 84043 1 1 0 0 President and CEO 0 Common Stock 2024-01-01 4 M 0 17001 0 A 648160 D Common Stock 2024-01-01 4 M 0 3233 0 A 651393 D Common Stock 2024-01-01 4 F 0 16550 6 D 634843 D Performance Stock Units 2024-01-01 4 M 0 17001 0 D Common Stock 17001 34003 D Performance Stock Units 2024-01-01 4 M 0 3233 0 D Common Stock 3233 9699 D On August 18, 2022, the reporting person was granted Performance Restricted Stock Units ("PSUs") which vest only to the extent specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as provided in the Form 4 filed by the reporting person on August 22, 2022. The reporting person initially reported the number of shares that were eligible to be earned at target-level performance achievement. The performance criteria were achieved at a level above target. The actual number of shares that vested was 133.13% of the at-target number of shares subject to vesting on that date. The number of PSUs beneficially owned following the reported transaction has been updated to reflect the number of earned units as well as the number of earned units remaining following the cancellation of 68,006 earned units, as reported on the Form 4 filed on November 8, 2023. On November 10, 2022, the reporting person was granted PSUs which vest only to the extent specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as provided in the Form 4 filed by the reporting person on November 15, 2022. The reporting person initially reported the number of shares that were eligible to be earned at target-level performance achievement. The performance criteria were achieved at a level above target. The actual number of shares that vested was 133.13% of the at-target number of shares subject to vesting on that date. The number of PSUs beneficially owned following the reported transaction has been updated to reflect the number of earned units as well as the number of earned units remaining following the cancellation of 9,700 earned units, as reported on the Form 4 filed on November 8, 2023. These shares were withheld to satisfy tax withholding obligations in connection with the vesting of a stock unit award granted to the reporting person on August 12, 2021, a PSU award and stock unit award granted to the reporting person on August 22, 2022, and a PSU award and stock unit award granted to the reporting person on November 10, 2022. PSUs convert into common stock on a one-for-one basis. Alissa Neufeld, Power of Attorney for Steven R. Fife 2024-01-03